Mirae Asset Global Investments Co. Ltd. Purchases Shares of 401,118 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 401,118 shares of the company’s stock, valued at approximately $32,587,000. Mirae Asset Global Investments Co. Ltd. owned 0.09% of GE HealthCare Technologies at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Aspire Private Capital LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $26,000. Center for Financial Planning Inc. purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter worth about $26,000. Larson Financial Group LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $27,000. Sanctuary Wealth Management L.L.C. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $28,000. Finally, Silvant Capital Management LLC purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $29,000. 79.18% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

GEHC has been the topic of a number of recent research reports. Citigroup initiated coverage on shares of GE HealthCare Technologies in a research report on Tuesday, September 19th. They set a “buy” rating and a $82.00 price target on the stock. Argus began coverage on GE HealthCare Technologies in a research report on Friday, August 25th. They issued a “buy” rating and a $80.00 price objective on the stock. Wells Fargo & Company began coverage on GE HealthCare Technologies in a research report on Wednesday, August 16th. They issued an “overweight” rating and a $90.00 target price for the company. Finally, Bank of America assumed coverage on GE HealthCare Technologies in a report on Monday, July 31st. They set a “neutral” rating and a $82.00 target price on the stock. Five equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $88.44.

GE HealthCare Technologies Stock Up 1.5 %

Shares of NASDAQ:GEHC opened at $73.00 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $53.00 and a 12-month high of $87.83. The company has a current ratio of 1.25, a quick ratio of 0.97 and a debt-to-equity ratio of 1.44. The firm has a market cap of $33.23 billion and a PE ratio of 21.73. The company has a fifty day simple moving average of $67.31 and a 200 day simple moving average of $73.26.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, October 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.10. The business had revenue of $4.82 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.91% and a return on equity of 24.46%. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.87 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 3.81 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Friday, October 20th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date of this dividend was Thursday, October 19th. GE HealthCare Technologies’s dividend payout ratio is presently 3.57%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.